Streetbeat News

Analyst Ratings

RLJ

Truist Securities analyst Gregory Miller has maintained a 'Buy' rating on RLJ Lodging (NYSE:RLJ), but lowered the price target from $15 to $14.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:32 pm

PNFP

Truist Securities analyst Jennifer Demba maintains a 'Buy' rating on Pinnacle Financial Partners (NASDAQ:PNFP) and raises the price target from $61 to $73.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:31 pm

PK

Truist Securities analyst Patrick Scholes maintains a 'Buy' rating on Park Hotels & Resorts (NYSE:PK) but lowers the price target from $20 to $19.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:30 pm

LNG

Cheniere Energy's (NYSE:LNG) short percent of float has fallen 14.89% since its last report, with 2.89 million shares sold short, which is 1.2% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. Compared to its peers, Cheniere Energy has less short interest as a percentage of float, with an average of 3.39%.

Portfolio Pulse from Benzinga Insights

July 20, 2023 | 2:30 pm

BIIB

Biogen's (NYSE:BIIB) short percent of float has fallen 6.9% since its last report, with 2.07 million shares sold short, which is 1.62% of all regular shares available for trading. It would take traders 2.03 days to cover their short positions on average. Compared to its peers, Biogen has less short interest as a percentage of float, with the average being 3.57%.

Portfolio Pulse from Benzinga Insights

July 20, 2023 | 2:30 pm

VC

JP Morgan analyst Ryan Brinkman maintains a Neutral rating on Visteon (NASDAQ:VC) and raises the price target from $156 to $157.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 2:30 pm

KKR

The short percent of float for KKR & Co (NYSE:KKR) has increased by 3.77% since its last report, with 10.68 million shares sold short. This represents 1.65% of all regular shares available for trading. Short interest can indicate market sentiment towards a stock, with an increase potentially signaling a more bearish outlook. However, KKR & Co's short interest as a percentage of float is less than its peer group average of 3.14%.

Portfolio Pulse from Benzinga Insights

July 20, 2023 | 2:30 pm

MRK

Truist Securities analyst Robyn Karnauskas has maintained a 'Buy' rating on Merck & Co (NYSE:MRK), but lowered the price target from $118 to $116.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 2:30 pm

DXPE

Zacks Home Run Investor Newsletter has picked DXP Enterprises (DXPE) as a stock to watch.

Portfolio Pulse from Happy Mohamed

July 20, 2023 | 2:29 pm

LEGN

Morgan Stanley has maintained an Overweight rating on Legend Biotech and raised its price target from $65 to $85. This has resulted in Legend Biotech's shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 2:29 pm